facebook twitter youtube rss
Pioneering innovative therapies to improve the lives of those with genetic intellectual disabilities

You are here

DRYK1A

Exciting New Research from Spain!

The Jerome Lejeune Foundation has been intensely involved in supporting the development of therapeutic treatments related to the overexpression of the gene

TesDAD

Among the hundreds of genes that are overrepresented in individuals with trisomy 21, a few are highly suspected to be at least partly responsible for cognitive impairment.

Newsletter Signup




ABOUT THE
Jerome Lejeune Foundation